Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.44 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.44 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5846680 | 0.83 | HTR7 (0.47) | HTR7HTR1ADRD2HTR2AALDH1A1 | |
| SCHEMBL29786265 | 0.83 | HTR7 (0.47) | HTR7HTR1ADRD2HTR2AALDH1A1 | |
| SCHEMBL12088921 | 0.74 | HTR2A (0.39) | HTR7HTR1ADRD2HTR2APARP1 | |
| SCHEMBL19130698 | 0.74 | HTR7 (0.42) | HTR7HTR1ADRD2HTR2APARP1 | |
| SCHEMBL2071403 | 0.74 | GRIN2D (0.44) | HTR7HTR1ADRD2HTR2AALDH1A1 | |
| SCHEMBL7498162 | 0.73 | HTR7 (0.41) | HTR7HTR1ADRD2HTR2AALDH1A1 | |
| SCHEMBL3669973 | 0.71 | HPGD (0.40) | HTR7HTR1ADRD2HTR2AMEN1 | |
| SCHEMBL7655280 | 0.71 | HSD17B10 (0.49) | MEN1KMT2AALDH1A1NPSR1TSHR | |
| SCHEMBL28481650 | 0.69 | HTR7 (0.36) | HTR7HTR1ADRD2HTR2ALMNA | |
| SCHEMBL906702 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7022724-B2 | Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands | MERCK SHARP & DOHME LTD. (GB) | 2006-04-04 | — | — | US | disclosed |
| US-20040058970-A1 | Cognition enhancing derivatives of isoxazole triazoloindane GABA-A alpha 5 receptor subunit ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058970-A1 | Cognition enhancing derivatives of isoxazole triazoloindane GABA-A alpha 5 receptor subunit ligands | GABRA5, GABRA1, GABRB1 | HTR7 277/4885HTR1A 198/4885DRD2 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.